Deals
Revance Therapeutics Secures $300M ATM via Cowen and Company
|
Revance Therapeutics (NASDAQ GM:RVNC) announced that it has secured up to $300,000,000 in an ATM (At the Market) transaction.
Growth Capitalist (https://growthcapitalist.com/category/deals/page/39/)
Recent growth capital transactions by pre-IPO private and public emerging growth companies
Revance Therapeutics (NASDAQ GM:RVNC) announced that it has secured up to $300,000,000 in an ATM (At the Market) transaction.
Argos Therapeutics (NASDAQ GM:ARGS) announced that it has raised $49,707,437 in a Common Stock transaction.
Uranium Energy Corporation (AMEX:UEC) announced that it has raised $10,509,999 in a Registered Direct transaction.
LabStyle Innovations Corporation (NASDAQ CM:DRIO) announced that it has raised $2,500,000 in a Common Stock transaction.